drug protocol number

LANTU_C_02762

drug sponsor

Sanofi

drug study

Lantus® / Glimepiride / human insulin [NPH]

drug trial site

King Fahad University Hospital (Al-Khobar), King Abdulaziz University Hospital (Jeddah)

drug status

Completed

drug phase